Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ACSL4: biomarker, mediator and target in quadruple negative breast cancer

12 Jun 2023

Abstract excerpt

// Marie E. Monaco 1 , 2 1 Department of Neuroscience and Physiology, NYU Grossman School of Medicine, New York, NY 10016, USA 2 VA NY Harbor Healthcare System, New York, NY 10010, USA Correspondence to: Marie E. Monaco, email: mem6@nyu.edu Keywords: ACSL4; breast cancer; ferroptosis; molecular subtype; quadruple negative breast cancer Received: November 07, 2022 Accepted: June 01, 2023 Published: June 12, 2023...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Inflammatory mediators and NSAID effects
Share to Peroxisome Proliferator-Activated Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37306503
DOI: 10.18632/oncotarget.28453

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ACSL4: biomarker, mediator and target in quadruple negative breast cancerPMID 37306503Read ↗

A Fatty Acid Metabolic Signature for Prognosis (FAMOUS) in Breast CancerSemantic proximity Read ↗

The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escapeSemantic proximity Read ↗

MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancerSemantic proximity Read ↗

A novel subtyping method for TNBC with implications for prognosis and therapySemantic proximity Read ↗

ESR1-Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer.Semantic proximity Read ↗

ADAR1 Regulates Lipid Remodeling to Dictate Ferroptosis SensitivitySemantic proximity Read ↗

LCN2: Versatile players in breast cancerSemantic proximity Read ↗

ACSL4 activity drives TNBC metastasis by positively regulating Histone H3 Acetylation mediated SNAIL expressionSemantic proximity Read ↗

Apocrine carcinoma of the breast: distinctive metabolic reprogramming and high-frequency PIK3CA mutations revealed by molecular and immunohistochemical analysis.Semantic proximity Read ↗

FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancerSemantic proximity Read ↗

Convergent suppression of nuclear-encoded mitochondrial fatty acid oxidation genes defines a pan-subtype signature in breast cancer: a multi-cohort transcriptomic studySemantic proximity Read ↗

The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.